CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification - Quiz - MDSpire

Evaluating CHA2DS2-VA and Non-CHA2DS2-VA Factors as Indicators of Mortality Following Cavotricuspid Isthmus Ablation: A Tool for Long-Term Risk Assessment

  • By

  • Kamilla Luca Dávid

  • Előd János Zsigmond

  • Manuella Bogdan

  • Balázs Polgár

  • Nikolett Vigh

  • Zalán Gulyás

  • Judit Papp

  • Emese Tóth-Zsámboki

  • Gábor Zoltán Duray

  • July 20, 2026

Share

Original Source(s)

CHA2DS2-VA and non-CHA2DS2-VA components as predictors of mortality after cavotricuspid isthmus ablation: a clinical tool for long-term risk stratification

  • by Kamilla Luca Dávid, Előd János Zsigmond, Manuella Bogdan, Balázs Polgár, Nikolett Vigh, Zalán Gulyás, Judit Papp, Emese Tóth-Zsámboki, Gábor Zoltán Duray

  • July 20, 2026

Related Content

Opioid and benzodiazepine requirements in neonatal and pediatric patients undergoing venoarterial ECMO: insights from a predominantly cardiac cohort

Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques – a pilot study

Assessing the diagnostic accuracy of cardisiography in the diagnosis of coronary heart disease: CSG-DR study (A pilot study)